You are here

Ophthalmic Viscoelastic Devices Market to Reach $3.22 Bn, Globally, by 2026 at 4.12% CAGR: Allied Market Research

Increase in prevalence of cataract & glaucoma worldwide, rise in government initiatives to control visual impairment, surge in adoption of ophthalmic viscoelastic devices across the globe, and escalation in number of ophthalmic surgeries propel the growth of the global ophthalmic viscoelastic devices market

PORTLAND, Oregon, July 11, 2019 /PRNewswire/ -- Allied Market Research published a report, titled, "Ophthalmic Viscoelastic Devices (OVD) Market by Product Type (Cohesive Ophthalmic Viscoelastic, and Dispersive Ophthalmic Viscoelastic), Application (Cataract Surgery, Glaucoma Surgery, Corneal Transplant and Vitreoretinal Surgery), and End User (Hospital, Ophthalmology Clinics, and Others): Global Opportunity Analysis and Industry Forecast, 2019–2026." The report provides a detailed analysis of drivers & opportunities, changing market trends, competitive market landscape, and market size & estimates. According to the report, the global ophthalmic viscoelastic devices market was estimated at $2.33 billion in 2018 and is expected to hit $3.22 billion by 2026, registering a CAGR of 4.1% during the forecast period.

Request Sample Report at: 

Rise in prevalence of cataract & glaucoma worldwide, surge in government initiatives to control visual impairment, growing adoption of ophthalmic viscoelastic devices across the globe, and increase in number of ophthalmic surgeries fuel the growth of the global ophthalmic viscoelastic devices market. On the other hand, high cost of ophthalmic surgeries and lack of advanced eye surgery devices & ophthalmic clinics restrain the growth to some extent. Nevertheless, high potential of the emerging economies is expected to create multiple opportunities for the frontrunners in the industry.

The cohesive ophthalmic viscoelastic segment to maintain its dominance till 2026-

Based on product, the cohesive ophthalmic viscoelastic segment accounted for more than two-thirds of the total market revenue in 2018 and is expected to dominate throughout the estimated period. The wide array of benefits they provide in cataract surgery such as creating & maintaining space in the anterior segment of the eye, and implanting & reducing deleterious vector forces drive the growth of the segment.

The hospitals segment to rule the roost-

Based on end user, the hospitals segment generated the highest share in 2018, contributing to more than half of the total market. The fact that hospitals always tend to have the availability of expensive eye surgery devices used during surgeries has impelled the growth of the segment.

North America to lead the trail during the study period-

Based on geography, North America contributed more than two-fifths of the total market share in 2018 and is anticipated to retain its top status through 2019–2026. This is attributed to high prevalence of cataract and rise in government initiatives to prevent visual impairment. Simultaneously, the Asia-Pacific region is projected to grow at the fastest CAGR of 5.5% till 2026.

For Purchase Enquiry at:

Key players in the industry-

The key market players analyzed in the report include Eyekon Medical Inc., Carl Zeiss Meditec AG, Cima Technology Inc, Johnson & Johnson, Altacor Haohai Biological Technology, Bausch Health Companies, Inc., Bohus Biotech Ab, Novartis International AG (Alcon Inc.), and Rumex International Corporation. Adhering to a number of high-end strategies including expansions, mergers & acquisitions, partnerships, joint ventures, collaborations, and others, these market players have become able to heighten their status in the industry.

Access KNOWLEDGE TREE (Premium on-demand, subscription-based pricing model) at:

Knowledge tree is a cloud-based intelligence platform that offers more than 2,000 selective, off-the-shelf reports on niche markets to enable our clients gain deep insights on the latest trends, dynamic technologies, and emerging application areas.

Similar Reports:

Ophthalmic Devices Market - Global Opportunity Analysis and Industry Forecast, 2014-2022

Ophthalmic Drugs Market - Global Opportunity Analysis and Industry Forecast, 2017-2023

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975